StorylineInformation society
Gene therapy for cholesterol
Cleveland Clinic conducted the first human trial of the experimental drug CTX310, which can halve levels of 'bad' cholesterol. Results indicated that the cholesterol-lowering effect has persisted for a year.
- 2 events
- 3 sources
- updated
Covered by 1 of 6 media groups
- Budget not in the collected reports
- Public money not in the collected reports
- Media business 3 sources
- Big capital not in the collected reports
- Readers and grants not in the collected reports
- Undisclosed not in the collected reports
Chronology
3 October
4 September
2 of 2 events